GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Synergy Pharmaceuticals Inc (SGYP) [hlAlert]

Rating:
Buy SGYP
up 53.75 %

Synergy Pharmaceuticals Inc (SGYP) rated Buy with price target $11 by Cantor Fitzgerald

Posted on: Monday,  Aug 12, 2013  8:25 AM ET by Cantor Fitzgerald

Cantor Fitzgerald rated Buy Synergy Pharmaceuticals Inc (NASDAQ: SGYP) on 08/12/2013. Previously Cantor Fitzgerald rated Buy Synergy Pharmaceuticals Inc (NASDAQ: SGYP) on
09/25/2012., when the stock price was $4.80. Since then, Synergy Pharmaceuticals Inc has gained 53.75% as of 01/05/2016's recent price of $7.38.
If you would have followed the previous Cantor Fitzgerald's recommendation on SGYP, you would have gained 53.75% of your investment in 1197 days.

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI) disorders and diseases. The Company?s lead drug candidate is SP-304, a guanylyl cyclase C (GC-C) receptor agonist, to treat GI disorders, primarily chronic constipation (CC) and constipation-predominant irritable bowel syndrome (IBS-C). SP-304 is an analog of uroguanylin, a natural GI hormone secreted in the gut, which is a key regulator of intestinal function. As of December 31, 2009, the Company was developing SP-304, a synthetic hexadecapeptide designed to mimic the actions of the GI hormone uroguanylin, for the treatment of CC and IBS-C. SP-304 is an agonist of GC-C. In February, 2010, a Phase IIa 14-day, repeated-oral-dose trial of SP-304 in CC patients opened for enrollment and was actively recruiting patients.

Cantor U.S. Equity Research provides timely and insightful opinions on select stocks. We look at key drivers of the stock price, including company and industry fundamentals, capital markets influences and overall economic trends to provide critical and in-depth analysis. Our focus is on small and mid-cap companies in the following sectors: * Marine Transportation * Life Sciences * Clean Technology & Energy Efficiency * Real Estate * Communications Technology * Internet * Enterprise Software
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/12/2013 8:25 AM Buy
None
4.54 11.00
as of 12/13/2013
1 Week down  -3.86 %
1 Month down  -1.16 %
3 Months down  -10.00 %
1 YTD down  -19.58 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/9/2013 8:25 AM Buy
None
6.39 15.00
1/2/2013 1:25 PM Buy
None
6.19 13.00
9/25/2012 8:25 AM Buy
None
4.80 7.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy